Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 4 of 16
Stereotactic Ablative Radiation Therapy for Prostate Cancer
NCT05668351
Tracking Brain Biomarkers and Renormalization Associated With Antidepressant Transcranial Magnetic Stimulation Therapy
NCT06043401
Improving Maternal Mental Health & SUD Screening and Treatment
NCT05764213
Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens
NCT05384223
Art and Physical Therapy in Pediatric HCT
NCT05441670
Daily Topical Rapamycin for Vitiligo
NCT05342519
Brief, High-dose rTMS for Depression
NCT04657432
FIT Families Multicomponent Obesity Intervention for African American Adolescents
NCT04974554
Evaluation of an "Opt-Out" Inpatient Smoking Cessation Service on Smoking Behavior Study #1
NCT04827914
Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE)
NCT04655963
Early Intervention Following Sexual Assault
NCT04582695
Dry Needling for Spasticity in Stroke
NCT04535479
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
NCT04482673
Peer Approaches to Lupus Self-management
NCT03734055
Epidural Cortical Stimulation for Depression
NCT00565617
Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)
NCT03101917
Olfactory Dysfunction in Aging Adults
NCT07660887
A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
NCT07398404
Predictors & Mechanisms of Adolescent PTSD
NCT07537764
OEA for Young Adults With Alcohol Use Disorder
NCT07503782
Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain
NCT07035119
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label
NCT07689773
Thermodynamic Exposure and Sleep in Military Cadets
NCT07201935
Low Intensity Focused Ultrasound in ASD
NCT07225322
Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound
NCT05792020
SimuVersity Medical Center: Pain and Opioid Management Training in Diverse Patient Populations
NCT06624124
fMRI Tracking taVNS in ASD
NCT06698328
mHealth Behavior Study
NCT06624514
VIDeOS for Smoking Cessation
NCT06307496
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
NCT06162663
Mastoid taVNS-fMRI
NCT06518356
Cognitive Priming for Stroke Tele-rehabilitation
NCT06555302
Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping
NCT06335329
Use of Vibration During Constraint-induced Movement Therapy
NCT06452576
Examine the Feasibility and Acceptability of Project Support
NCT06391229
Post-stroke Pain taVNS
NCT06456385
vHIT Testing for Presentation of Dizziness at a Comprehensive Stroke Center
NCT06038175
CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes
NCT06087328
Accelerated rTMS for Post-Stroke Apathy
NCT05878457
CEUS For Intraoperative Spinal Cord Injury
NCT05530798
Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
NCT06034925
Do Therapy Dogs Improve Behavior and Reduce Anxiety in Pediatric Dental Patients?
NCT06057090
Neuromodulation and Dynamic Balance in Stroke
NCT05135533
GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
NCT05875636
Mechanisms of Smell Improvement With Dupilumab.
NCT05964465
Effects of GLP-1 Agonists on Gastric Volume
NCT05854979
Transcranial Focused Ultrasound (tFUS) Modulation of Reward Network
NCT05986019
Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation
NCT06105541
Hypothermia's Effect on Hepatitis B Vaccination
NCT05787899
Safety Assessment of Central Medial Thalamus Stimulation Using Transcranial Focused Ultrasound
NCT05895474
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.